AU784404B2 - Nuclear matrix proteins, polynucleotide sequences encoding them, and their use - Google Patents

Nuclear matrix proteins, polynucleotide sequences encoding them, and their use Download PDF

Info

Publication number
AU784404B2
AU784404B2 AU15703/01A AU1570301A AU784404B2 AU 784404 B2 AU784404 B2 AU 784404B2 AU 15703/01 A AU15703/01 A AU 15703/01A AU 1570301 A AU1570301 A AU 1570301A AU 784404 B2 AU784404 B2 AU 784404B2
Authority
AU
Australia
Prior art keywords
antibody
nmp
cell
prostate
cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU15703/01A
Other languages
English (en)
Other versions
AU1570301A (en
Inventor
Robert H. Getzenberg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Pittsburgh
Original Assignee
University of Pittsburgh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Pittsburgh filed Critical University of Pittsburgh
Publication of AU1570301A publication Critical patent/AU1570301A/en
Application granted granted Critical
Publication of AU784404B2 publication Critical patent/AU784404B2/en
Priority to AU2006202828A priority Critical patent/AU2006202828A1/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU15703/01A 1999-10-15 2000-10-16 Nuclear matrix proteins, polynucleotide sequences encoding them, and their use Ceased AU784404B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2006202828A AU2006202828A1 (en) 1999-10-15 2006-06-30 Nuclear matrix proteins, polynucleotide sequences encoding them, and their use

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/418,839 US6617432B1 (en) 1999-10-15 1999-10-15 Nuclear matrix proteins polynucleotide sequences encoding them and their use
US09/418839 1999-10-15
PCT/US2000/028498 WO2001029218A2 (en) 1999-10-15 2000-10-16 Nuclear matrix proteins, polynucleotide sequences encoding them, and their use

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU2006202828A Division AU2006202828A1 (en) 1999-10-15 2006-06-30 Nuclear matrix proteins, polynucleotide sequences encoding them, and their use

Publications (2)

Publication Number Publication Date
AU1570301A AU1570301A (en) 2001-04-30
AU784404B2 true AU784404B2 (en) 2006-03-30

Family

ID=23659754

Family Applications (1)

Application Number Title Priority Date Filing Date
AU15703/01A Ceased AU784404B2 (en) 1999-10-15 2000-10-16 Nuclear matrix proteins, polynucleotide sequences encoding them, and their use

Country Status (8)

Country Link
US (3) US6617432B1 (enExample)
EP (2) EP1228210B1 (enExample)
JP (1) JP2003512391A (enExample)
AT (1) ATE405646T1 (enExample)
AU (1) AU784404B2 (enExample)
CA (1) CA2387864A1 (enExample)
DE (1) DE60040010D1 (enExample)
WO (1) WO2001029218A2 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030228640A1 (en) * 1999-10-15 2003-12-11 University Of Pittsburgh Nuclear matrix proteins, polynucleotide sequences encoding them, and their use
JP4560314B2 (ja) * 2004-03-17 2010-10-13 ジェイファーマ株式会社 中性アミノ酸トランスポーターによる癌の検出法、及びそのためのキット

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5308835A (en) * 1984-07-09 1994-05-03 Praxis Biologics, Inc. Production of the E. coli LT-B enterotoxin subunit
US5273877A (en) * 1985-12-24 1993-12-28 Massachusetts Institute Of Technology Non-histological cell type determination
US4882268A (en) * 1985-12-24 1989-11-21 Massachusetts Institute Of Technology Method for determining tissue of origin and degree of malignancy of tumor cells
DE4012454C1 (enExample) * 1990-04-19 1991-08-08 Fraunhofer-Gesellschaft Zur Foerderung Der Angewandten Forschung E.V., 8000 Muenchen, De
CA2122473C (en) * 1991-10-31 2001-01-23 Lee Anne Beausang Nuclear matrix protein fluid assay
CA2138807A1 (en) 1992-06-22 1994-01-06 Gary Toukatly Novel malignant cell type markers of the interior nuclear matrix
JPH08508396A (ja) * 1993-02-09 1996-09-10 ザ ジョーンズ ホプキンス ユニバーシティー スクール オブ メディシン 核マトリックスタンパク質
US5547928A (en) * 1993-12-17 1996-08-20 Matritech, Inc. Methods and compositions for the detection of colon cancers
AUPM885194A0 (en) * 1994-10-14 1994-11-10 Council Of The Queensland Institute Of Medical Research, The Synthetic peptides and vaccines comprising same
AU7394296A (en) * 1995-10-19 1997-05-07 Bristol-Myers Squibb Company Monoclonal antibody br110 and uses thereof
AU7474696A (en) 1995-11-03 1997-05-22 Robert R. Bahnson Bladder nuclear matrix proteins and their use in detecting and treating cell proliferative disorders
US20030228640A1 (en) * 1999-10-15 2003-12-11 University Of Pittsburgh Nuclear matrix proteins, polynucleotide sequences encoding them, and their use

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
KONETY BR ET AL,PROCEEDINGS OF RESEARCH ANNUAL VOL.37, P 73 *

Also Published As

Publication number Publication date
ATE405646T1 (de) 2008-09-15
DE60040010D1 (de) 2008-10-02
WO2001029218A3 (en) 2002-03-07
EP1228210B1 (en) 2008-08-20
AU1570301A (en) 2001-04-30
CA2387864A1 (en) 2001-04-26
EP1702984A3 (en) 2006-10-18
EP1228210A2 (en) 2002-08-07
EP1702984A2 (en) 2006-09-20
US6617432B1 (en) 2003-09-09
US20030170754A1 (en) 2003-09-11
WO2001029218A2 (en) 2001-04-26
US20050181418A1 (en) 2005-08-18
JP2003512391A (ja) 2003-04-02

Similar Documents

Publication Publication Date Title
US5824490A (en) Method for detecting prostate cancer using a reagent which binds prostate cancer-1 protein
US5866535A (en) Bladder nuclear matrix proteins, polynucleotide sequences encoding them, and their use
US6951926B2 (en) Antibody to bladder cancer nuclear matrix protein and its use
AU784404B2 (en) Nuclear matrix proteins, polynucleotide sequences encoding them, and their use
US6232443B1 (en) Renal nuclear matrix proteins, polynucleotide sequences encoding them, and their use
US7531634B2 (en) Bladder matrix protein peptides and methods of detection of bladder cancer
AU2006202828A1 (en) Nuclear matrix proteins, polynucleotide sequences encoding them, and their use
US20030228640A1 (en) Nuclear matrix proteins, polynucleotide sequences encoding them, and their use
AU2004201412A1 (en) Bladder nuclear matrix proteins, polynucleotide sequences encoding them, and their use